The Chinese government on 9 May issued proposals to amend the implementing rules of the existing national Drug Administration Law, the paramount legislation regulating the pharmaceutical industry in the country.
The changes are being perceived as providing new support and a renewed policy tailwind to Chinese drug makers, although the...